•Halper Sadeh LLC is investigating whether the $135.11 per share cash acquisition price offered by AbbVie for Apogee Therapeutics is fair to shareholders.
•SG Americas Securities significantly increased its stake in TransDigm by purchasing 53,823 additional shares, bringing its total investment value to $116.9 million.
•Maestria Partners LLC designated TDG as its 10th largest holding at 5.8% of its portfolio, despite cutting its stake by 24.8% in Q1.
•The company reaffirmed optimistic FY2026 EPS guidance following strong Q1 results that exceeded estimates.
•Revvity launched Signals AI, a native agentic framework within its Signals One platform, allowing scientists to interact with R&D data using natural language.
•Firm Capital Property Trust announced the completion of the Competition Bureau of Canada inquiry regarding its acquisition of 50% interests in ten manufactured home communities.
•The total purchase price for the portfolio is $218 million, executed through an existing joint venture with SunPark Communities.
